Anidulafungin for the treatment of candidaemia caused by Candida parapsilosis : Analysis of pooled data from six prospective clinical studies

Changing epidemiology of candidaemia in Australia

(2017) Belinda Chapman et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Executive Summary: Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America

(2016) Peter G. Pappas et al.   CLINICAL INFECTIOUS DISEASES

The distribution and drug susceptibilities of clinical Candida species in TSARY 2014

(2016) Zi-Li Zhou et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Comparative effectiveness of echinocandins versus fluconazole therapy for the treatment of adult candidaemia due to Candida parapsilosis : a retrospective observational cohort study of the Mycoses Study Group (MSG-12): Table 1.

(2016) Kathleen Chiotos et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

A Prospective Surveillance Study of Candidaemia: Epidemiology, Risk Factors, Antifungal Treatment and Outcome in Hospitalized Patients

(2016) Ranjith Rajendran et al.   Frontiers in Microbiology

Multicenter Study of Epidemiological Cutoff Values and Detection of Resistance in Candida spp. to Anidulafungin, Caspofungin, and Micafungin Using the Sensititre YeastOne Colorimetric Method

(2015) A. Espinel-Ingroff et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Invasive Candidiasis

(2015) Bart Jan Kullberg et al.   NEW ENGLAND JOURNAL OF MEDICINE

Evaluation of an early step-down strategy from intravenous anidulafungin to oral azole therapy for the treatment of candidemia and other forms of invasive candidiasis: results from an open-label trial

(2014) Jose Vazquez et al.   BMC INFECTIOUS DISEASES

Initial Use of Echinocandins Does Not Negatively Influence Outcome in Candida parapsilosis Bloodstream Infection: A Propensity Score Analysis

(2014) Mario Fernández-Ruiz et al.   CLINICAL INFECTIOUS DISEASES

Editorial Commentary: Is the Debate About Treatment of Candida parapsilosis Complex Infections With Echinocandins Much Ado About Nothing?

(2014) A. C. Reboli   CLINICAL INFECTIOUS DISEASES

Intravenous anidulafungin followed optionally by oral voriconazole for the treatment of candidemia in Asian patients: results from an open-label Phase III trial

(2013) Piroon Mootsikapun et al.   BMC INFECTIOUS DISEASES

Epidemiology, Species Distribution, Antifungal Susceptibility, and Outcome of Candidemia across Five Sites in Italy and Spain

(2013) M. Bassetti et al.   JOURNAL OF CLINICAL MICROBIOLOGY

An open-label study of anidulafungin for the treatment of candidaemia/invasive candidiasis in Latin America

(2013) Marcio Nucci et al.   MYCOSES

Impact of Treatment Strategy on Outcomes in Patients with Candidemia and Other Forms of Invasive Candidiasis: A Patient-Level Quantitative Review of Randomized Trials

(2012) D. R. Andes et al.   CLINICAL INFECTIOUS DISEASES

Anidulafungin for the treatment of candidaemia/invasive candidiasis in selected critically ill patients

(2012) M. Ruhnke et al.   CLINICAL MICROBIOLOGY AND INFECTION

Caspofungin Use in Patients with Invasive Candidiasis Caused by Common Non-albicans Candida Species: Review of the Caspofungin Database

(2010) A. L. Colombo et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001-2007)

(2009) Nikolaos V. Sipsas et al.   CANCER

Early Clinical Experience with Anidulafungin at a Large Tertiary Care Medical Center

(2007) Benjamin D Brielmaier et al.   PHARMACOTHERAPY